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ABSTRACT         ARTICLE INFO______________________________________________________________     ______________________
The use of meshes has become the first option for the treatment of soft tissue disor-
ders as hernias and stress urinary incontinence and widely used in vaginal prolapse’s 
treatment. However, complications related to mesh issues cannot be neglected. Various 
strategies have been used to improve tissue integration of prosthetic meshes and redu-
ce related complications. The aim of this review is to present the state of art of mesh 
innovations, presenting the whole arsenal which has been studied worldwide since 
composite meshes, coated meshes, collagen’s derived meshes and tissue engineered 
prostheses, with focus on its biocompatibility and technical innovations, especially for 
vaginal prolapse surgery.
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Soft tissue surgery has become the most 
common surgical procedure in western countries as 
a result of population aging as well as over-weight 
and obesity increasing (1). On this scenario, the use 
of meshes has become the first option in the treat-
ment of hernia and urinary incontinence (UI) and 
widely used in pelvic organ prolapse (POP) treat-
ment due to the high recurrence rates after primary 
suture techniques (2). For instance, it is supposed 
that about 11% of the women will undergo surgery 
to POP repair in their lifetime, and 30% of these 
patients will need reoperation because of prolapse 
recurrence within 4 years post-surgery (3).
POP’s pathophysiology remains unclear. 
The strength of the pelvic floor depends on the in-
terplay of properly innervated muscles, ligaments, 
and connective tissue. The etiology of prolapse 
is likely multifactorial, developing from obstetric 
trauma and denervation to the pelvic floor, as well 
as altered collagen and connective tissue metabo-
lism in pelvic floor tissues (2).
 Polypropylene (PP) materials became one 
of the most popular meshes implanted for soft 
tissue repair (1) due to flexibility, cellular growth 
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and inflammatory response patterns, easy mani-
pulation and low price (4).
Despite its popularity, complications rela-
ted to mesh issues cannot be neglected, including 
infection and exposure of the prosthesis or erosion 
of vaginal wall for transvaginal implantation (5). 
Many of adverse effects are related to poor inte-
gration of the materials at the implantation site 
resulting in marked inflammation and ischemic 
phenomena, which delays the healing process (6). 
Such concerns about mesh problems in POP’s tre-
atment led the United States Food and Drug Ad-
ministration (FDA) and the UK’s National Institute 
for Health and Clinical Excellence (NICE) to pu-
blish recently warning statements regarding use 
of synthetic mesh for pelvic floor reconstruction 
based on the absence of level I evidence suppor-
ting its efficacy and safety (7).
To improve the outcome of surgical treat-
ment of POP, different types of surgical implants 
have been launched over the last decade (8) and 
various strategies have been used to optimize tis-
sue integration of prosthetic meshes in order to 
reduce complications.
The aim of this review is to perform a lite-
rature review of the state of the art on mesh’s use 
for vaginal prolapse surgery focused on its bio-
compatibility and technical innovations.
MATERIALS AND METHODS
 Online searches through Pubmed, Embase 
and Web of Science were conducted using the sear-
ch terms “mesh(es)”, “biomaterials”, “innovations“, 
“urinary incontinence”, “prolapses”, “biocompatibi-
lity” and “integration”. Priority was given to publi-
cations within the past 5 years in English language. 
Abstracts were reviewed and 58 studies were selec-
ted and subsequent suitable full texts manuscripts 
obtained. Of those, 7 studies were excluded for pre-
senting data only related to hernia’s treatment and 
3 studies were excluded due to the lack of a reliable 
description of methodology. The level of evidence of 
each study is presented.
MESH BIOCOMPATIBILITY
It is worthy to define mesh biocompatibility 
to better understand which strategies have recently 
been developed and tested for reducing complica-
tions and improving clinical results. It is basically 
determined by the foreign body reaction (FBR) and 
is totally connected to mesh integration.
 The highly dynamic process of the FBR is 
considerably influenced by the biomaterial compo-
sition and its specific features. For instance, it has 
been well established in the literature that monofi-
lament polypropylene mesh with large porous elicits 
a more biocompatible FBR resulting in better inte-
gration than multifilament and small porous size. 
Amid (9) devised a classification based on pore size 
for meshes used in hernia repairs (Table-1), which is 
commonly used for PP meshes description.
 Graft options have evolved over years, 
and include autografts, allografts, xenografts and 
synthetic materials (Table-2). Surgeon preference 
for graft material has varied widely, and for each 
material its own inherent advantages and disad-
vantages have been described (10).
 Modifications of the polymer’s chemical 
composition, material weight, filament structure 
and pore size have substantial effects in the in vivo 
Table 1 - Amid’s Classification of Synthetic Biomaterials.
Type I Totally macroporous mesh with pores >75μm, the size required for infiltration of macrophages, fibroblasts, blood vessels
Type II: Totally microporous mesh with pores <10μm in at least one of three dimensions
Type III: Macroporous material with multifilamentous or microporous components
Type IV: Materials with submicronic pore size
Ref: 9-Amid PK: Classification of biomaterials and their related complications in abdominal wall hernia surgery. Hernia. 1997;1:15-2.
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biocompatibility and are potential parameters to 
be studied in order to improve clinical results.
RESEARCHES ON NEW POP PROSTHESIS
 We have didactically divided researches 
into 5 topics that will further be presented:
A. Composite Meshes
B. Changes In Mesh Density And Pore Sizes
C. Coating Biomaterials
D. Collagen Derived Biomaterials
E. Tissue Engineered Protheses (TEP)
A. COMPOSITE MESHES
 Theoretically, the rationale of using a 
composite mesh is to associate an absorbable com-
ponent, which will reduce the amount of foreign 
material in the host without compromising the 
mechanical resistance in the end of the integra-
tion process. Moreover, absorbable components 
can act as a long lasting dressing during healing 
period (11, 12). Recently, many combinations have 
been tested (PP+polyglactin; PP+polysaccharide 
hydrogel) with different Levels of Evidence (LE).
 1. PP+Polyglactin (PG)
 Clinical studies using polyglactin have al-
ready been published. In 2001 Weber et al. (13) 
compared three techniques of anterior colporrha-
phy: standard; standard plus polyglactin 910 mesh; 
or ultralateral anterior colporrhaphy, and conclu-
ded that the addition of polyglactin 910 mesh did 
not improve the cure rate compared with standard 
anterior colporrhaphy and provided similar anato-
mic cure rates and symptom resolution for ante-
rior vaginal prolapse repair. In 2005, an observa-
tional study involving 90 patients was conducted 
with retrospective chart review and prospective 
subjective and objective assessments at the end of 
a 1-year study period to access the results of col-
porrhaphy with a composite vicryl-polypropylene 
mesh. Surgical correction was achieved in 27 of 
31 (83.9%) at 6 months and beyond and there was 
no mesh infection but minor vaginal mesh protru-
sion was found in 7 of 90 (7.8%) patients at 6-12 
weeks and 4 of 31 (12.9%) patients at 6 months 
and beyond. The conclusion was that posterior 
colporrhaphy with mesh was effective in treating 
posterior vaginal prolapse (14).
 Experimental studies about this subject 
are also available. Junge et al., in an experimental 
study using 60 male Sprague-Dawley rats, found 
benefits of using a partially absorbable (PG+PP) 
mesh in terms of a reduced amount of biomaterial 
after implantation and absorption of the absor-
bable part when compared with a standard non-
-absorbable PP mesh (15) (LE: 5). However, some 
studies found an increased inflammation induced 
by polyglactin (13, 14). After implantation in a 
standardized rodent animal model, The Vypro II 
(PP+PG) presented with increased inflammatory 
and fibrotic reaction in comparison with PP group 
(16) (LE: 5). Also, Weyhe et al. (17) described in-
creased levels of IL-6 and suppressed levels of 
transforming growth factor-beta 1 in the compo-
site mesh group, using an NRK-49F (mixed culture 
of normal rat kidney cells) fibroblast culture.
 2. PP+Polysaccharide Hydrogel
 A hybrid mesh (HM) composed of poly-
propylene mesh embedded in a polysaccharide 
hydrogel was studied after intramuscular and 
subcutaneous implantation in rats in compari-
son with two clinically used materials. Histolo-
gical and mechanical aspects were analyzed and 
the authors concluded that HM’s use is promising 
because it is easy to make, easily implanted, and 
once inserted produces little foreign body reac-
tion, creating a well-balanced integration with the 
tissue environment. Further, using the properties 
of this hydrogel to deliver substances locally (gro-
wth factors, antibiotics, etc.) can be used to regu-
late tissue colonization (18) (LE: 5).
Table 2 - Biomaterials Options For Soft Tissue Repair.
Natural Synthetic
Autografts (rectus fascia, 
fascia lata, vaginal wall);
Allografts (cadaveric tissues, 
including dura mater, dermis, 
fascia lata);
Xenografts (porcine small 
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B. CHANGES IN MESH DENSITY AND PORE SIZES
 Theoretically, low-density meshes would 
optimize the FBR by reducing the mass of the ma-
terial used and diminishing its contact interface 
with the host tissue (19). However, there are stu-
dies with conflicting results regarding the real ad-
vances brought in by low-density meshes. Klinge 
et al. (20) examined meshes with different pore 
sizes and weight in a rat abdominal model and 
found that lightweight meshes had superior tissue 
integration, reduced inflammation, and reduced 
fibrosis compared with the heavyweight mesh, 
which corresponded to a reduction in cell turno-
ver in the lightweight meshes (LE: 5). In a review, 
Weyhe et al. (21) concluded that light meshes se-
emed to present certain advantages in relation to 
postoperative pain and the foreign-body feeling, 
but were associated with a greater recurrence rate 
(LE: 1A).
C. COATING BIOMATERIALS
 Biomaterial surface properties play an im-
portant role. The use of some agents for coating 
biomaterials is based on their ability to mask the 
underlying surface by producing a hydrophilic in-
terface. These coating layers improve the device/
host tissue interactions and consequently improve 
device functionality and life span (22, 23). Various 
materials are currently used for a device coating, 
including natural or synthetic polymeric materials 
(24) (Table-3), each one of these with a particular 
purpose, such as antiadhesive, infection protec-
tion and protection against foreign body reaction.
 1. Corticosteroids Coating
 As therapeutic drugs, corticosteroids have 
been used for their immunosuppressive benefits 
in daily practice for decades. Recent emphasis 
on their effects on tissue remodeling and fibro-
sis in FBR underline their therapeutic potential 
(25). Brandt et al. developed a mouse model to 
investigate the role of the mineralocorticoid and 
glucocorticoid’s receptors in FBR around steroid-
-coated polyvinylidenfluoride (PVDF) meshes. 
Early modification of corticosteroid receptor ac-
tivity can attenuate local inflammatory response 
to foreign bodies with subsequent beneficial long-
-term effects. Further investigations should clarify 
dose response, the protective potential of a com-
bination of both protective substances, and whe-
ther similar effects could be achieved by systemic 
delivery of drugs (26) (LE: 5).
 2. Plasma
 Animal experiments support the hypothesis 
that autologous modification of alloplastic materials 
by coating with plasma leads can improve early in-
tegration of the respective material into the different 
locations. Gerullis et al. (27) implanted coated and 
uncoated version of three different mesh types, all 
of them with previously in vitro proved biocompa-
tibility. They demonstrated significant less FBR, scar 
formation and inflammatory reaction for the plasma 
coated material in each type of mesh after 3 and 6 
months with the following ranking order: (1) Dy-
namesh-CICAT™; (2) Ultrapro™; (3) TVTO™ (LE: 2). 
Accordingly, it was found an improved cell adhe-
sion on alloplastic meshes covered with autologous 
plasma compared to non-covered meshes including 
eighteen different commonly used alloplastic mate-
rials (28).
 3. Titanium-Coated Mesh
Titanium is considered to be an inert ma-
terial and has been used for decades in orthopedic 
and dental implants. As a coating, it is thought to 
resist to degradation at room temperature due to 
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a thin and stable protective oxide layer that forms 
on its surface.
Titanium-coated PP meshes have more 
recently come into use in the field of pelvic re-
constructive surgery and hernia repair. However, 
studies of titanized meshes used for hernia repair 
in animal models have not clearly shown any su-
perior benefit, with no significant differences (29) 
or even greater inflammation (15) (LE: 5). Moreo-
ver, titanium-coated polypropylene meshes have 
no particular advantages in infected tissue (30) 
and safety’s concern still needs to be clarified (31) 
(LE: 5).
 4. PP+Poly(Vinyl Alcohol)
 Prudente et al. (32) impregnated mono-
filament PP meshes with physically cross-linked 
poly (vinyl alcohol) (PVA). The PVA deposits were 
also used as reservoirs for the local release of S-
-nitrosoglutathione (GSNO), a nitric oxide (NO) 
donor. Histological analysis of the abdominal 
wall, 21 days after the implant in rats, revealed 
lower edema (p=0.0039) and greater angiogenesis 
(p=0.0031), based on immunehistochemical ex-
pression of CD-31 surface antigen surrounding the 
implant (LE: 5). A marked decrease of NO concen-
tration in the tissue surrounding the impregnated 
meshes was observed after 2 days (Figure-1) and 
authors concluded that improvements in FBR were 
due to hydrophilicity changes in the local micro-
environment around the mesh.
 5. Antibiotics
An anti-infective drug-eluting mesh that 
slowly delivers antibiotic around the surgical site 
could be used to avoid bacterial contamination of 
the prosthesis and subsequent biofilm formation. 
The local delivery system offer several advantages 
over systemic administration: greater efficacy, lo-
wer drug dose required, less toxicity due to the lo-
cal release of the drug, extended activity and less 
likelihood of promoting antimicrobial resistance 
(33, 34) (LE: 1A). A new antibiotic-eluting system 
was developed on a pre-existing type IPP mesh 
Figure 1 - Composite Mesh: PVA/GSNO-40-impregnated PP mesh. Representative micrograph of the subcutaneous tissue 
surrounding filaments of PP meshes 21 days after implantation in the subcutaneous tissue of Wistar rats. A) HE 100×; Plain 
PP mesh (control). B) HE 100×; PVA/GSNO-40-impregnated PP mesh. C) HE 400×. Plain PP mesh. D) HE 400×; PVA/GSNO-
40-impregnated PP mesh. Note the presence of fewer spaces among collagen fibers around the filaments in (B) which means 
lower edema; Note the higher amount of vessels (arrows) in (D) which means greater angiogenesis.
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used for the treatment of genital prolapse, without 
having an impact on the intrinsic properties of the 
material, and proved to decrease post-operative 
short-term infection (1) (LE: 3).
 6. Silver-Coated Mesh
For many years, silver has been a precious 
metal that is used in several fields of medicine and 
surgery for its anti-infectious properties (35). A 
study compared silver-coated and non-silver-co-
ated large pore monofilament PP mesh implants 
with and without infection (four groups) inserted 
in the abdominal wall of 84 female Wistar rats. An 
Escherichia coli strain was inoculated intraopera-
tively in the two infected groups. The implants 
were removed, and clinical, bacteriological, and 
histological analysis were performed at 2, 15, and 
30 days postoperatively. All inoculated rats (n=21) 
in the non-silver-coated PP group presented pe-
riprosthetic E. coli infection, compared with only 
five inoculated rats in the silver-coated PP group 
(p<0.0001). Erosion was significantly higher in 
the infected than in the non-infected silver-coa-
ted PP groups (p<0.01). There was no histological 
difference between the four groups. They conclu-
ded that silver-coated implants appear effective 
against bacterial infection, with good histological 
tolerance but delayed healing (LE: 5). However, 
the potential cytotoxicity of silver, as well as bio-
mechanical properties of polypropylene after the 
release of silver nanoparticles, require further stu-
dies (36).
D. COLLAGEN DERIVED BIOMATERIALS
Collagen-based biomaterials have been 
available for several decades and are becoming 
increasingly popular due to their perceived bio-
compatibility and low immunogenicity (37).
 1. Collagen Coating
Collagen type I has been used as a coating 
for polypropylene mesh because of its unique bio-
logical properties. It is the most abundant protein 
in the mammalian connective tissues. Its structu-
re is very conservative and therefore it does not 
induce an immune reaction even if a xenogeneic 
material is used. It enhances and augments growth 
of mesothelial cells that act as an antiadhesive 
layer (38). Some reports have confirmed the utility 
of collagen foil as such a barrier (39).
Concerning urogynecology surgeries, 
some interesting studies are available. Huffaker et 
al. (40) used a rabbit vagina model to compare 
tissue responses to two PP meshes: uncoated PP 
mesh (Gynemesh PSTM) versus collagen-coated PP 
mesh (PelvitexTM) at 12 weeks and found similar 
scores for inflammation, neovascularization, and 
fibroblastic proliferation, but a higher apopto-
tic activity in the collagen-coated group (0.39% 
vs.0.1%; p: 0.04) (LE: 5). De Tayrac et al. used a 
sheep vagina model (41), and concluded that a de-
layed tissue integration was observed in the colla-
gen-coated mesh one week after implant, despite a 
non-significant higher rate of vaginal erosions in 
the uncoated group (33% vs. 6.7%; p:0.4) (LE: 5). 
Other authors also suggest that use of a collagen-
-coated PP mesh for vaginal prolapse repair may 
help reduce erosions and dyspareunia (42) (LE: 3) 
and the mechanism involved could be due to the 
lesser adhesion of the coated mesh on the vaginal 
wound during the early postoperative period. On 
the other hand, reports on increased susceptibility 
to infections and lack of long-term effectiveness 
of such a coating have been published (43) (LE: 2).
 In an experimental study, PP mesh coating 
with a new highly purified collagen gel consisting 
of type I collagen obtained from bovine tendon 
was implanted in a rat model and showed an in-
crease of adherence of the mesh to the neighbo-
ring tissue, less intense and persistent lymphocyte, 
plasma cell, and granulomatous reaction and a 
higher birefringence level of the collagen fibers, 
thus reflecting an improved molecular organiza-
tion of newly formed collagen and a positive re-
modeling action in mesenchymal repair involving 
polypropylene mesh (44) (LE: 5) (Figure-2).
 2. Porcine Small Intestinal Submucosa (SIS)
 Porcine small intestinal submucosa (SIS) is 
an almost acellular biomaterial, which is derived 
from the submucosal layer of pig small intestine 
and exhibits several characteristics that are ad-
vantageous for sling placement: its extracellular 
matrix promotes ingrowth of cells that remodel it 
into functional host tissues; its cytokines attract 
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host cells and promote angiogenesis; it is strong, 
easily sutured, and can be easily manufactured to 
match the physical properties of the tissue being 
replaced; and elicits only a mild immunologic 
response (45). In a comparative study between 
PP and non-cross-linked porcine small intestine 
serosal-derived collagen implants in a rat model, 
SIS induced a less pronounced inflammatory re-
action, less dense adhesions and an architecturally 
better collagen organization than PP. SIS shows 
an obvious transient weakness in tensile strength 
at 30 days compared with PP but this difference 
does not persist (46) (LE: 5).
E. TISSUE ENGINEERED PROTHESES (TEP)
 Recent advances in cell-based technology 
using regenerative medicine techniques suggest 
that this approach holds enormous potential to 
improve human conditions by encompassing al-
teration of the current biological state of a tar-
geted tissue, augmentation of depleted function, 
or absolute functional tissue replacement (47). To 
that end, numerous cell-based investigations have 
been performed to address urinary incontinence. 
Cells derived from various sources have been used 
for urinary incontinence, including chondrocytes, 
smooth muscle cells, muscle precursor cells, adi-
pose-derived stem cells, and bone marrow stro-
mal cells providing coaptation of the bladder neck 
by augmenting tissue mass or restoring sphincter 
function (48).
The potential use of cell-based tissue engi-
neering strategies to treat POP appears to be more 
intricate. The vagina is a complex organ with gre-
at demands of functionality, and parameters such 
Figure 2 - Highly Purified Collagen Gel Coating Polypropilene Mesh presenting higher birefringence level of collagen fibers, 
thus reflecting an improved molecular organization of newly formed collagen. A and B) Image of section impregnated 
with silver (Ag) 90 days after implantation. PP (A) and PP+C (B) where the packing arrangement of collagen fibers is 
demonstrated. Ag, 40×1. C and D) Unstained section immersed in water (PP+C 90 days after implantation), showing filament 
cut perpendicularly, through collagen fibers with various brightness intensities. Birefringence is revealed by brightness 
contrasted with a dark background. B. Same image, after compensation, in which collagen fibers appear dark.
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as strength and elasticity of the native tissue vary 
interpersonally (49). Furthermore, the pathologi-
cal anatomy of POP dictates that a simple injec-
tion of cells to regenerate damaged vaginal tissue 
is not feasible. Besides these limitations, a novel 
tissue engineering approach for creating prosthe-
ses for the treatment of stress urinary incontinen-
ce and pelvic organ prolapse has been described. 
TEP were made from stromal fibroblasts, obtained 
from oral mucosal biopsies, cultured in Dulbecco’s 
Modified Eagle’s medium (DMEM) on an electros-
pun fabric of Poly(L)lacticco glycolic acid (PLGA) 
polymer. This technique allows for ingrowth of 
cells with the intrinsic ability to produce collagen. 
So far, only limited evidence exists, and additional 
animal studies are imperative before this approach 
is ready for clinical use (50).
DISCUSSION
 This review was based on a compilation of 
selected studies concerning mesh and biomaterials 
innovations using Pubmed, Embase and Web of 
Science databases. It is important to emphasize the 
lack of good quality clinical studies and the great 
difficult to compare them due to different methodo-
logies. Moreover, the majority of studies are experi-
mental and current literature does not have a reliable 
animal model for stress urinary incontinence and/or 
prolapse repair. Although it has already been tes-
ted by numerous previous experiments to evaluate 
graft and prosthesis integration, the rat subcuta-
neous tissue surely is not the ideal experimental 
model. In current literature different models have 
been tested with interesting findings, including 
rabbit and sheep’s vagina models (40, 41). Thus, 
those results cannot just be extrapolated to clini-
cal practice. However, despite this weakness, such 
review can be useful as a brief exposition of mesh 
innovations and strategies under development for 
biocompatibility improvement (Table-4).
 The major controversy is still the use of me-
shes for pelvic organ prolapse repair. The literature 
does not have strong evidences, which support their 
use for that purpose as a routine. Therefore, conti-
nuous research is needed in order to find an ideal 
biomaterial, with an adequate size, weight and fea-
tures for lowering the risk of infection and integra-
tion defects. Moreover, as concluded by Barski et al. 
in a meta-analysis, careful individualized selection 
of patients and materials, education of patients, and 
elimination of identified risk factors are urgent prior 
to implantation of vaginal meshes (51).
 The vagina is considered a clean-contami-
nated field. Mesh complications, such as erosion, 
may be linked to bacterial contamination at the time 
of mesh insertion (2). The properties of the mesh 
play an important role in lowering the infection 
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risk. The major concern is related to vaginal pro-
lapse surgery, in which the size of the meshes and 
positioning in the vagina differs substantially from 
the sub-urethral tapes (52).
Comments on each topic
 A. Composite Meshes
Recently, many combinations of com-
posite meshes have been tested (PP+olyglactin; 
PP+polysaccharide hydrogel; PP+polyvinyl alcohol) 
but with conflicting results. It is important to state 
that some evidences are based on experimental stu-
dies without an adequate control, and with a short 
follow-up (18). Moreover, some conclusions were ba-
sed on in vitro studies (15-17).
 B. Changes In Mesh Density And Pore Sizes
 Concerning the ideal mesh weight, light or 
ultralight meshes tend to become first choice, becau-
se of its better biocompatibility, but still needs further 
improvements to avoid the risk of higher recurrence 
rate.
 C. Coating Biomaterials
 Coating agents seems to be a great potential 
strategy, highlighting antibiotic and corticosteroid 
coating with interesting preliminary in vitro results. 
Silver and titanium’s use should have its cytotoxicity 
and biomechanical aspects clarified.
 D. Collagen Derived Biomaterials
Due to its availability, biocompatibility, 
low immunogenicity and favorable biological pro-
perties (37), collagen is an imminent candidate on 
biomaterial’s scenario. However, just few trials are 
available with different collagen preparations. As 
other biological products, there is a wide range of 
purification, decellularization and cross-linked tre-
atments among collagen preparations presented, 
making comparisons difficult.
 E. Tissue Engineered Protheses (TEP)
 Cell-based technology will surely become 
one of the most relevant approaches for soft tissue 
disorders in a few years. However, so far, only li-
mited evidence exists and, especially considering 
POP’s treatment, cell-based tissue engineering is 
still just speculation.
CONCLUSIONS
 Biomaterials research have recently emer-
ged worldwide as a result of an urgent need for 
more appropriate options for reconstructive medi-
cine and treatment of soft tissue disorders. Com-
posite or coated meshes intending to get antia-
dhesive profile, protection against infection or to 
elicit less pronounced foreign body reaction have 
been tested. Although significative basic scien-
ce information has been produced, there are still 
conflicting results. Also, tissue-engineering tech-
niques have shown only limited evidence till now. 
As the life expectancy is growing quickly, efforts 
in biomaterials research must be reached, in order 
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